Plain-English translation of NCT06276309 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is trying to better understand a rare type of cancer called cervical neuroendocrine tumors by studying the proteins found in tumor tissue samples. Researchers will collect medical information and tissue samples from 300 women who have been diagnosed with this condition to identify which protein patterns may help predict how the disease will progress and which patients might have better or worse outcomes.
Cervical neuroendocrine tumors are uncommon and doctors still don't fully understand what makes some patients do better than others after treatment. By studying the proteins in these tumors, researchers hope to discover markers that could help doctors predict prognosis more accurately and eventually guide treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you enroll, the research team will review your medical records, pathology results, and follow-up information to learn about your diagnosis, treatment, and how you've done over time. For some participants, a portion of tissue from your original biopsy or surgery may be analyzed to study its protein makeup. There are no additional visits or procedures required beyond what you're already doing for your regular cancer care.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China